Advertisement
Home Tags Drug Approvals

Tag: Drug Approvals

The Fenix Continence Restoration System has been approved by the U.S. Food and Drug Administration to treat an inability to control bowel movements for patients who can't tolerate or use other approved methods.

FDA Approves New Device for Fecal Incontinence

0
Viable surgical option when medical measures have failed
The LifeVest wearable defibrillator has been approved by the U.S. Food and Drug Administration for children at risk for cardiac arrest who can't have a defibrillator implanted. The device is already approved for adults.

FDA Approves LifeVest Wearable Defibrillator for Children

0
For heart patients who can't have device implanted
Bridion (sugammadex) has been approved by the U.S. Food and Drug Administration to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide.

FDA Approves Bridion to Reverse Neuromuscular Blockade

0
Drug reverses the effects of rocuronium bromide and vecuronium bromide
Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of the chemotherapy drugs fluorouracil and capecitabine

FDA Approves Vistogard to Treat Chemotherapy Overdose

0
For overdose of the chemo drugs fluorouracil and capecitabine
Alecensa (alectinib) has been approved by the U.S. Food and Drug administration to treat anaplastic lymphoma kinase-positive non-small-cell lung cancer

FDA Approves Alecensa for ALK-Positive NSCLC

0
Drug is designed to block the effects of the ALK protein
The Dignitana DigniCap Cooling System cap has been approved by the U.S. Food and Drug Administration to help prevent hair loss in women undergoing chemotherapy for breast cancer.

FDA Approves Cooling Cap to Reduce Chemo-Linked Hair Loss

0
Designed for women diagnosed with breast cancer
Kanuma (sebelipase alfa) has been approved by the U.S. Food and Drug Administration as the first treatment for LAL deficiency (Wolman disease or cholesteryl ester storage disease).

FDA Approves Kanuma for Lysosomal Acid Lipase Deficiency

0
For treatment of LAL deficiency, also known as Wolman disease or cholesteryl ester storage disease
Vonvendi has been approved by the U.S. Food and Drug Administration to treat adults with von Willebrand disease.

FDA Approves Vonvendi to Treat von Willebrand Disease

0
Approved for the as-needed treatment and control of bleeding episodes in adults
The first seasonal influenza vaccine with an adjuvant has been approved for use in seniors

FDA Approves First Flu Vaccine Containing an Adjuvant

0
Adjuvant can enhance or direct the immune response of the vaccinated individual
Empliciti (elotuzumab)

FDA Approves Empliciti for Multiple Myeloma

0
Monoclonal antibody works with another approved therapy to provide additional benefit